Back to search
FDAFDA · Food and drugs·Recall number D-0536-2023

Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.

Published April 26, 2023 · Recall initiated: March 16, 2023

Summary

FDA records drug Class II recall D-0536-2023, published April 26, 2023 and initiated March 16, 2023. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 695 cartons; Lot: Lots: 1008622, 1010026, Exp 2/29/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of specification dissolution results above specified values.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA
Lot
Lots: 1008622, 1010026, Exp 2/29/24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7. recalled?

Yes. FDA published recall D-0536-2023 on April 26, 2023. Reported hazard: Failed Dissolution Specifications: Out of specification dissolution results above specified values.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone